Inhibition of arterial lesion progression in CD16-deficient mice: evidence for altered immunity and the role of IL-10
Open Access
- 30 August 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 85 (1) , 224-231
Abstract
Given the importance of IgG Fc receptors in immune regulation, we hypothesized that Fcg receptor type III (FcgRIII, CD16) plays an important role in atherogenesis. We therefore analysed the formation of arterial lesions in LDL receptor-deficient (LDLR−/−) and FcgRIII−/−×LDLR−/− double knockout mice at three different points up to 24 weeks of exposure to a high-fat diet. Analysis of Oil Red-O-stained sections revealed no difference in lesion formation between strains after 6 weeks of a high-fat diet, and a modest decrease after 14 weeks in double knockouts relative to LDLR−/− controls. After 24 weeks, lesion formation was decreased in the aortic root (30%) and innominate artery (50%) in FcgRIII double knockouts relative to LDLR−/− controls. Analysis of peripheral CD4+ T-cells by intracellular flow cytometry from double knockouts after 24 weeks of a high-fat diet revealed statistically significant increases in the percentages of cells producing interferon-γ, interleukin (IL)-10, and IL-4 relative to controls, differences that were also observed by analyses of whole aortas for cytokine mRNA levels. As determined by flow cytometry, FcgRIII deficiency resulted in an expansion of CD4+ cells and an increase in the CD4 to CD8 ratio. Analysis of plasma anti-oxidized LDL (OxLDL) antibodies by chemiluminescent assay revealed that IgG1 and IgG2c titers to OxLDL were increased in FcgRIII −/−×LDLR−/− double knockouts relative to LDLR−/− controls, while total IgG levels were similar. These results reveal altered immunity in FcgRIII−/−×LDLR−/− mice and a reduction in lesion formation associated with increased production of IL-10 by an expansion of CD4+ T-cells. The reduction in lesion formation was manifest well after evidence of an immune response to OxLDL, suggesting that FcgRIII contributes to lesion progression in murine atherosclerosis.Keywords
This publication has 53 references indexed in Scilit:
- The role of innate immunity in atherogenesisJournal of Lipid Research, 2009
- CD11c + Dendritic Cells Maintain Antigen Processing, Presentation Capabilities, and CD4 + T-Cell Priming Efficacy Under Hypercholesterolemic Conditions Associated With AtherosclerosisCirculation Research, 2008
- Signaling through FcγRIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammationJournal of Experimental Medicine, 2007
- Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of diseaseProceedings of the National Academy of Sciences, 2006
- Depletion of Natural Killer Cell Function Decreases Atherosclerosis in Low-Density Lipoprotein Receptor Null MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Influence of Interferon-γ on the Extent and Phenotype of Diet-Induced Atherosclerosis in the LDLR-Deficient MouseArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Innate and acquired immunity in atherogenesisNature Medicine, 2002
- B-Lymphocyte Deficiency Increases Atherosclerosis in LDL Receptor–Null MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient MiceImmunity, 1996
- FcR γ chain deletion results in pleiotrophic effector cell defectsCell, 1994